Funded by USAID and led by Management Sciences for Health and its consortium of
partners, the goal of the five-year Medicines, Technologies, and Pharmaceutical Services (MTaPS) program (2018–2023) is to help low- and middle- income countries
strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and pharmaceutical services.